Recent News

AZ’ Lynparza hits targets in ovarian cancer trial

AstraZeneca has unveiled data from a late-stage trial showing that Lynparza improved progression free survival (PFS) in patients with a certain form of ovarian cancer when used in the maintenance setting.


Original Link...

Tags: medical, MEDICINE, pharmaceuticals
0 Volde

Read On: